2m 2m 2m 2m 2m 2m 2m
Scynexis (SCYX)
NASDAQ
$3.82$0.00 (0.00%)
Price as of Jun 23, 2026 4:10 PM EDT- $37.7MMarket Cap
- -34.93%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Scynexis (SCYX)
$3.82$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4M -61.45% | 3.7M -97.33% | 140.1M +2,652.72% | 5.1M -61.32% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.4M -61.45% | 3.7M -97.33% | 140.1M +2,652.72% | 5.1M -61.32% | |
Sales and Marketing Expense | 14.4M -0.44% | 14.5M -30.89% | 20.9M -66.77% | 63.0M +26.13% | |
Research and Development Expense | -22.3M -15.62% | -26.4M -14.62% | -30.9M +13.46% | -27.3M +14.66% | |
Depreciation and Amortization Expense | N/A N/A | 0 -100.00% | 580,000 -4.29% | 606,000 +59.89% | |
Total Operating Expenses | 36.7M -10.25% | 40.9M -39.44% | 67.5M -25.73% | 90.8M +22.77% | |
Operating Profit | -16.1M -56.69% | -37.1M -151.08% | 72.7M +184.74% | -85.8M +40.96% | |
Interest Income | 2.2M -49.27% | 4.3M +8.52% | 4.0M +179.43% | 1.4M +5,795.83% | |
Interest Expense | N/A N/A | N/A N/A | -3.1M -39.78% | -5.2M +95.41% | |
Interest Income and Expense and Net | 2.2M -49.27% | 4.3M +420.75% | 824,000 +121.78% | -3.8M +43.51% | |
Total Nonoperating Income and Expense | 7.5M -53.29% | 16.0M +391.07% | -5.5M -130.09% | 18.2M -26.67% | |
Income before Taxes | -8.6M -59.27% | -21.1M -131.46% | 67.2M +199.51% | -67.5M +87.76% | |
Income Taxes | 0 -100.00% | 151,000 +9.42% | 138,000 +102.94% | -4.7M +52.20% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -8.6M -59.56% | -21.3M -131.75% | 67.0M +206.74% | -62.8M +91.11% | |
Net Income from Continuing Operations Applicable to Common | -8.6M -59.27% | -21.1M -131.46% | 67.2M +199.51% | -67.5M +87.76% | |
Basic EPS and Net Income | -0.17 -61.36% | -0.44 -131.43% | 1.40 +195.24% | -1.47 N/A | |
Diluted EPS and Net Income | -0.17 -61.36% | -0.44 -131.65% | 1.39 +194.56% | -1.47 +17.60% | |
Basic Weighted Average Shares | 49.9M +2.93% | 48.5M +1.38% | 47.9M +12.29% | 42.6M +61.51% | |
Diluted Weighted Average Shares | 49.9M +2.93% | 48.5M +0.25% | 48.4M +13.56% | 42.6M +61.51% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 21.3M +32.45% | 16.1M -52.86% | 34.0M -25.68% | 45.8M -56.15% | |
Short-Term Investments | 18.8M -56.60% | 43.2M +7.29% | 40.3M +45.59% | 27.7M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 40.0M -32.49% | 59.3M -20.25% | 74.4M +1.17% | 73.5M -29.65% | |
Total Current Assets | 40.4M -44.07% | 72.2M -29.31% | 102.1M +29.16% | 79.1M -27.72% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 533,000 +27.82% | 417,000 N/A | 0 -100.00% | 5.5M -9.98% | |
Total Assets | 59.0M -34.88% | 90.6M -29.41% | 128.4M +46.24% | 87.8M -26.73% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 5.7M -76.21% | 24.1M +47.82% | 16.3M -7.46% | 17.6M +29.39% | |
Total Long-Term Debt | N/A N/A | 35.4M N/A | 0 -100.00% | 34.4M +19.65% | |
Total Long-Term Liabilities | 3.9M -65.84% | 11.5M -57.51% | 27.0M N/A | 0 -100.00% | |
Total Liabilities | 9.7M -72.86% | 35.6M -35.86% | 55.5M -34.44% | 84.6M +7.63% | |
Retained Earnings | -385.1M +2.29% | -376.5M +5.99% | -355.2M -15.88% | -422.3M +17.47% | |
Total Stockholders Equity | 49.4M -10.35% | 55.1M -24.51% | 73.0M +2,156.79% | 3.2M -92.16% | |
Total Shares Outstanding | 43.5M +14.66% | 38.0M +2.06% | 37.2M +13.85% | 32.7M +13.85% | |
Cash Flow | |||||
Cash from Operating Activities | -5.3M -78.00% | -24.0M -139.91% | 60.2M +175.31% | -79.9M +46.41% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 24.3M +295.22% | 6.2M +117.63% | -34.9M +27.34% | -27.4M +2,236.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -14.2M +10,094.24% | -139,000 -99.62% | -36.7M -175.55% | 48.6M -27.59% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,113.16% +12.34% | -990.84% -2,010.83% | 51.85% +103.08% | -1,684.48% +264.46% | |
Return on Assets | -11.50% -40.81% | -19.44% -131.34% | 62.01% +202.50% | -60.50% +104.66% | |
Return on Equity | -16.48% -50.43% | -33.25% -118.90% | 175.97% +162.33% | -282.34% +174.97% | |
Revenue Growth | -61.45% -36.86% | -97.33% -103.67% | 2,652.72% +4,425.79% | -61.32% N/A | |
Current Ratio | 7.04 +135.08% | 3.00 -52.18% | 6.26 +39.58% | 4.49 -44.14% | |
Cash Ratio | 3.71 +456.68% | 0.67 -68.11% | 2.09 -19.68% | 2.60 -66.11% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 10.64 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.39 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow